The Chinese company ran large clinical trials suggesting that in local patients, it appeared just as effective as Lilly's (LLY) Zepbound in helping patients lose weight. Tesla (NASDAQ:TSLA) Chief ...

The Chinese company ran large clinical trials suggesting that in local patients, it appeared just as effective as Lilly’s bestselling Zepbound in helping patients lose weight. The treatment also ...

The World Health Organization continues its investigation into the origins of COVID-19, with significant information still ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

If you’ve been waiting for the chance for weight loss injections to drop in price, there are more options turning up to ...

Of the 102,166 GLP-1s analyzed, 94% had some form of commercial insurance, yet cost-saving options were still widely overlooked.

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

As Ohio cuts off state employees' coverage of medications for weight loss, a lawmaker who has benefited from the drugs wants ...